1-7 of 7
Sangeeta Krishnan, PharmD, MS
Close
Sort by
Journal Articles

Clinical Burden of Paroxysmal Nocturnal Hemoglobinuria Among Patients Receiving C5 Inhibitors in the United States

David Dingli, MD PhD, Joana E. Matos, PhD, Kerri Lehrhaupt, BSc, Sangeeta Krishnan, PharmD, MS, Sujata P. Sarda, PhD, Scott B. Baver, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 2.
https://doi.org/10.1182/blood-2020-141844
Published: 2020
Journal Articles

Work Productivity Loss and Quality of Life in Paroxysmal Nocturnal Hemoglobinuria Among Patients Receiving C5 Inhibitors in the United States

David Dingli, MD PhD, Joana E. Matos, PhD, Kerri Lehrhaupt, BSc, Sangeeta Krishnan, PharmD, MS, Scott B. Baver, PhD, Sujata P. Sarda, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3.
https://doi.org/10.1182/blood-2020-142327
Published: 2020
Journal Articles

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population

Wendy Y Cheng, PhD MPH, Sujata P. Sarda, PhD, Nikita Mody-Patel, PharmD, MBA, Sangeeta Krishnan, PharmD, MS, Mihran Yenikomshian, MBA, Patrick J. Scoble, PharmD, Colin Kunzweiler, PhD MS, Jensen Duy Vu, BA, Hoi Ching Cheung, BA, Mei Sheng Duh, ScD, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 13.
https://doi.org/10.1182/blood-2020-141636
Published: 2020
Journal Articles

Real-World Treatment Patterns and Healthcare Resource Utilization (HRU) of Patients (Pts) with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population

Wendy Y Cheng, PhD MPH, Sujata P. Sarda, PhD, Nikita Mody-Patel, PharmD, MBA, Sangeeta Krishnan, PharmD, MS, Mihran Yenikomshian, MBA, Patrick J. Scoble, PharmD, Malena Mahendran, MSc, Dominique Lejeune, MSc, Louise Yu, MSc, Mei Sheng Duh, ScD, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-141648
Published: 2020
Journal Articles

Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison

Rachel Y Bhak, MS, Nikita Mody-Patel, PharmD, MBA, Scott B. Baver, PhD, Colin Kunzweiler, PhD MS, Christopher Yee, ScM, Sanjana Sundaresan, ScM, Natalia Swartz, MPH, Mei Sheng Duh, ScD, MPH, Sangeeta Krishnan, PharmD, MS, Sujata P. Sarda, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-141667
Published: 2020
Journal Articles

The Changing Costs of Caring for Hemophilia Patients in the U.S.: Insurers’ and Patients’ Perspectives

Adi Eldar-Lissai, PhD MS, Qiang Hou, PhD, Sangeeta Krishnan, PharmD, MS
Journal: Blood
Blood (2014) 124 (21): 199.
https://doi.org/10.1182/blood.V124.21.199.199
Published: 2014
Journal Articles

Psychometric Evaluation Of Health-Related Quality Of Life Assessments From The Along and Blong Hemophilia Clinical Trials

Kathleen W Wyrwich, PhD, Priscilla Auguste, MHS, Robyn von Maltzahn, MS, Ren Yu, MA, Sangeeta Krishnan, PharmD, MS, Nigel Dodd, MSc, Sylvia von Mackensen, PhD
Journal: Blood
Blood (2013) 122 (21): 423.
https://doi.org/10.1182/blood.V122.21.423.423
Published: 2013